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Abstract
Community delivery of Antiretroviral therapy (ART) is a novel innovation to increase sustainable ART coverage for People 
living with HIV (PLHIV) in resource limited settings. Within a nested cluster-randomised sub-study in two urban communi-
ties that participated in the HPTN 071 (PopART) trial in Zambia we investigated individual acceptability and preferences 
for ART delivery models. Stable PLHIV were enrolled in a cluster-randomized trial of three different models of ART: 
Facility-based delivery (SoC), Home-based delivery (HBD) and Adherence clubs (AC). Consenting individuals were asked 
to express their stated preference for ART delivery options. Those assigned to the community models of ART delivery arms 
could choose (“revealed preference”) between the assigned arm and facility-based delivery. In total 2489 (99.6%) eligible 
individuals consented to the study and 95.6% chose community models of ART delivery rather than facility-based delivery 
when offered a choice. When asked to state their preference of model of ART delivery, 67.6% did not state a preference of 
one model over another, 22.8% stated a preference for HBD, 5.0% and 4.6% stated a preference for AC and SoC, respectively. 
Offering PLHIV choices of community models of ART delivery is feasible and acceptable with majority expressing HBD 
as their stated preferred option.
Keywords HIV · Anti-retroviral therapy · Home-based ART delivery · Adherence clubs · Stated preference
Introduction
By the end of 2016, 36.7 million [30.8–42.9 million] people 
were living with HIV globally with the vast majority living 
in low-and middle-income countries [1]. East and Southern 
Africa are the most affected regions with approximately 
19.4 million People living with HIV (PLHIV) accounting 
for more than half the world’s HIV-positive population [1]. 
As the world commits to reaching the UNAIDS 90-90-90 
targets for HIV diagnosis, treatment, and viral suppression 
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by 2020 to end the AIDS epidemic by 2030, there has been 
substantial progress in scaling up Antiretroviral treatment 
(ART) programs globally. By 2018, more than 2/3 (79%) of 
all PLHIV knew their status with 23.3 million (62%) PLHIV 
accessing ART [2].
Zambia has an estimated HIV prevalence of 11.3% in 
adults with an estimated 1.2 million PLHIV [3], most in 
urban areas. The government, in close partnership with its 
PEPFAR implementing partners has made tremendous pro-
gress over the last decade towards epidemic control with 
63% of Zambians in need of ART receiving it by the end of 
2016 [3–6]. Following the adoption of the WHO [8] treat-
ment guidelines there has been an expansion in numbers 
of people on ART to about 85% of PLWH who know their 
status [7–10]. In spite of these successes, the ART treatment 
program in Zambia still faces many challenges. From the 
demand point of view, the change in guidelines increased the 
demand for ART services resulting in overcrowding, long 
waiting times and overburdening of the already fragile health 
facility system thus increasing the workload and burnout for 
the few existing health care workers [11, 12]. These chal-
lenges compromise service delivery and may lead to ART 
interruption, poor adherence, ongoing transmission and the 
development of viral drug resistance and increased mortality 
[9, 10, 13]. Adherence to treatment and virological suppres-
sion are critical for survival and prevention of onward viral 
transmission and without a change in the current delivery 
model of ART in Zambia, lifelong ART for all PLHIV is 
unsustainable. Decentralization of ART services into the 
community through community-based ART delivery models 
is one of the WHO recommended strategies to maintain the 
HIV continuum of care in resource limited settings where 
the existing formal health systems are unable to cope with 
increasing numbers of PLHIV on treatment [13].
Community-based models decentralize HIV services 
leading to improved service delivery by reducing conges-
tion at health facility, maintaining capacity of clinic staff 
and enhancing access to ART and adherence for PLHIV 
allowing them to have more power to coordinate their lives 
between treatment and livelihood options. These models 
have proven to be effective in a number of settings, empow-
ering patients on ART and communities to take respon-
sibility for their own treatment [14, 15]. In many settings 
across sub-Saharan Africa (SSA), these models have shown 
promising outcomes in relation to retention and adherence to 
treatment and strengthening community engagement by link-
ing community based programs with the existing health care 
facilities [13, 16–18]. These models are designed for “sta-
ble” patients, i.e., those on suppressive ART, to receive HIV 
services in the community thus reducing frequent clinic and 
pharmacy visits, transport costs and long waiting times and 
allowing the health care facility to focus more on patients 
with advanced disease. The models have been divided into 
four categories: health care worker-managed group mod-
els; client-managed group models; facility-based individual 
models; and out-of-facility based individual models [19].
The recently ended HPTN 071 (PopART) trial was a 
community randomized trial conducted in 21 urban com-
munities in Zambia and South Africa investigating whether 
a community-wide combination HIV prevention package 
including home-based HIV testing, linkage to care and 
immediate ART for those who test positive will help reduce 
HIV incidence [20, 21]. Early data from the PopART inter-
vention in Zambia showed that there were delays in initia-
tion of treatment [21]. Community based approaches to ART 
delivery have the potential to improve linkage and retention 
in care and hence help bridge this gap. The design of the 
PopART intervention, where universal door to door HIV 
services were provided by trained Community HIV provid-
ers (CHiPs), provided us with a unique opportunity to pilot 
different models of ART delivery with support from the 
Zambian Ministry of Health. Despite several pilot programs 
having achieved remarkable success across many settings in 
sub Saharan Africa [22–24], much about the comparisons 
between community models of ART delivery and conven-
tional facility-based delivery has been in relation to retention 
in care and on treatment and the frequency of clinical visits. 
Very few have compared different models of ART deliv-
ery with each other, in particular through soliciting patient 
preferences for different models of ART delivery [25]. In 
addition to providing evidence on long term outcomes, cost 
effectiveness, uptake and acceptability of different models 
of ART delivery, determining patient preferences towards 
these models will allow national HIV programs to design 
and implement models of ART delivery that work best and 
most appealing to patients in various settings.
To this effect, a three-arm cluster-randomized non-infe-
riority trial was nested in two of the HPTN 071 (PopART) 
trial intervention communities with the aim of evaluat-
ing clinical outcomes, feasibility and effectiveness of two 
community models of ART delivery (Adherence clubs 
and Home-based delivery) for stable HIV+ patients in an 
urban high HIV prevalence setting in Lusaka, Zambia. In 
this paper we describe choices (“revealed preferences”) and 
stated preferences of PLHIV for ART delivery models out-
side the health facility.
Methods
Study Design and Participants
The study was nested in two communities that had been part 
of the HPTN 071 (PopART) trial. Details of the main HPTN 
071 (PopART) trial have been described elsewhere [26]. We 
conducted a three-arm cluster-randomized non-inferiority 
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trial to compare virological suppression at 12 months in sta-
ble HIV+ patients receiving ART between individuals allo-
cated to receive either ART via community models of ART 
delivery and those receiving in the facility-based (standard 
of care). The two Lusaka communities chosen for this sub-
study resembled other PopART communities in Zambia and 
reflected the situation with respect to clinic burden HIV 
prevalence and population migration for many sub-Saharan 
African countries urban settings in resource limited settings.
The two communities selected for this cluster randomized 
trial were matched by community size and HIV prevalence 
(18% and 21% amongst adults aged 18–44). Each commu-
nity was divided into geographical zones of approximately 
500 households (approximately 1400 individuals) and each 
zone was managed by a pair of trained Community health 
workers (CHWs). There were 104 zones across the two 
communities.
All adult HIV+ patients (≥ 18 years) defined as “stable” 
in accordance with WHO definitions [19] residing in the 
two urban communities, enrolled for ART in the two pri-
mary health care facilities serving the communities, were 
eligible for inclusion in this nested study. WHO classifi-
cation for “stable “patients, was (1) Taking first line ART 
for at least 6 months, (2) Virally suppressed according to 
national guidelines, and (3) Had no other health conditions 
requiring the attention of a clinician. An additional eligibil-
ity criterion for our study included patients living within 
the HPTN 071 catchment area and being willing to provide 
written informed consent.
Randomization
The 104 zones across the two communities were randomly 
assigned (35:35:34) to one of the three study arms for ART 
delivery. The three study arms were: Arm 1. Facility-based 
ART delivery (Standard of care, (SoC) continued collec-
tion of ART only at the health care facility, Arm 2. Home-
based ART delivery (HBD) where ART was delivered to the 
participant’s home every 3 months by a community health 
worker (HCW) and Arm 3. Being part of an Adherence club 
(AC), meeting every 3 months outside of the health care 
facility and facilitated by a community health worker. In 
the HBD and AC arms participants were given the choice to 
continue with ART delivery through the health care facility 
or to accept the community model of ART delivery route 
they had been allocated. To achieve balance across the clus-
ters, we stratified randomization by community and further 
restricted the randomization, first within each community 
and second across both communities on average values of 
key outcomes including population size, HIV prevalence 
which was available at the entire community level only, and 
proportion of HIV+ patients who attend the local health care 
facility and distance to the health care facility to ensure over-
all balance across the study arms.
A public randomization ceremony was held with the com-
munity health workers, their supervisors, the primary health 
care staff, members of the PopART intervention study teams 
and community advisory boards to allocate the zones to one 
of the three study arms.
Study Outcomes: Participant’s ART Delivery Choices 
(Revealed Preference) and Stated Preferences
This study explores the participants ART delivery prefer-
ences, these have been divided into stated and revealed 
preferences; stated preferences are those which people say 
they want and revealed preferences are what they actually 
choose. The community models of ART intervention were 
implemented between 3rd May 2017 and 30th April 2019. 
All eligible patients attending the health care facility were 
invited to join the study and were asked to consent. Hav-
ing consented to the study, participants were assigned to a 
study arm. Those who were assigned to the two community 
models of ART delivery arms were first asked to choose 
between the assigned interventions and or continue with 
facility-based care (SoC), their revealed preference. Partici-
pants who were assigned to the facility-based (SoC) arm did 
not have an option to choose. Subsequently all participant’s 
(including those in the SoC) were asked “did you have a pre-
ferred model of ART delivery out of the three options? If yes, 
which model of delivery?”. The response to this question we 
define as the participant’s stated preference and can be one 
of the four categories: (1) Prefers Facility-based (SoC); (2) 
Prefers Home Based ART delivery; (3) Prefers Adherence 
clubs and (4) No preference expressed.
In this paper we describe the revealed preferences made 
by those in the two community models of ART delivery 
arms (as to whether they chose facility-based (SoC) or the 
allocated community model of ART delivery) and the stated 
preference of all participants about the different models of 
ART delivery. The stated and revealed preferences were 
recorded on the enrolment form by the study staff. Partici-
pant characteristics with regard to age, sex and years on 
ART were also collected as part of the general survey dur-
ing enrolment. All data were entered into an electronic data 
collection system.
Statistical Analysis
STATA version 13 was used to clean and analyse the data. 
Descriptive data on the study participants reported prefer-
ences were stratified by study arm and presented as medi-
ans and interquartile ranges for the continuous variables 
and proportions for the categorical variables. Of patients 
who consented to participate in the study, we determined 
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the proportion who chose the model of delivery assigned to 
them and the proportion of participants who stated a prefer-
ence for each model of ART delivery (or no preference). We 
further conducted analysis by sex, age group, years on ART 
and trial arm to explore whether there were any associa-
tions between these variables and stated preference using 
Pearson’s Chi square test.
An exploratory qualitative study using observations, 
interviews and Focus group discussions (FGDs) was used to 
collect qualitative data. Observations of Home based model 
delivery (HBM) (n = 12) and Adherence club meetings 
(n = 6), audio-recorded in-depth interviews with a purpo-
sively selected sample of PLWH accessing ART through the 
two models (n = 27) and two FGDs with community health 
workers administering the models (n = 16) were conducted 
eight months after the start of the intervention between Octo-
ber and December 2017 and at the end of the study between 
May and August 2019. Observations provided insights into 
how community health workers conducted the delivery of 
ART as well as the micro-social environment surrounding 
clients. Interviews and FGDs inquired about preferences and 
experiences of PLWH with accessing ART and acceptability. 
All discussions ended with participants plotting their overall 
opinion of the models on a simple visual scale with differ-
ent facial expressions (emoji’s) corresponding to degrees of 
satisfaction and acceptability.
All audio recordings from FGDs and IDIs were tran-
scribed verbatim and translated to English by the second 
author. Notes taken during and after the observation were 
expanded and typed in Word and then later on saved with 
a unique code representing each participant. All data tran-
scripts including typed notes were imported into Atlas.ti 7 
and using the Thematic coding analysis (TCA) approach, 
all parts of the data transcripts were subjected to iterative 
coding process by the first author [27, 28]. Analytical cat-
egories of related codes and sub codes were then stratified 
by study site and participant profile. Using Atlas ti 7, code 
outputs [codes linked to quotations from transcripts and 
summed up in a theme] were created representing recurrent 
themes related to factors influencing choice of a model and 
acceptability and served as a basis for further analysis and 
interpretation.
Ethics
The study was granted ethical clearance from the Univer-
sity of Zambia Biomedical Research Ethics (UNZABREC) 
and the London School of Hygiene and Tropical Medicine 
ethics committee. Prior to approval, this protocol had also 
been through regulatory review and approved by Division 
of AIDS (DAIDS) who granted us permission to carry out 
this study as an ancillary study to HPTN 071 (PopART) 
and registered at ClinicalTrials.gov. Further approvals were 
granted by Zambian National Health Research Authority and 
Ministry of Health. Written informed consent was obtained 
from all participants.
Results
A total of 2499 eligible participants were identified across 
the two communities between May and December 2017 who 
were eligible for inclusion in the trial and of these, 2489 
(99.6%) consented to participate, 10 (0.4%) declined consent 
(Fig. 1). The three study arms were well balanced accord-
ing to baseline characteristics, However there were fewer 
participants in the SoC arm. Of the participants who were 
eligible, the majority were female across all arms (N = 1757, 
71%), reflecting the stable patient clinic population on ART. 
The median age of participants was 40 years (IQR: 33–47) 
in the SoC and AC arms and 39 years (IQR: 33–46) in the 
HBD arm. The median years being on ART was 4 years 
(IQR: 2–7) across all three arms.
Choices of Models of ART Delivery in the Two 
Community Models of ART Delivery Arms
There were 781 (31.4%) stable participants were assigned 
to the SoC arm, 852 (34.2%) assigned to HBD arm and 856 
(34.4%) to AC arm. Of the participants who were assigned 
HBD, 27 (3.2%) chose to continue receiving care at the 
clinic and 48 (5.6%) who were assigned AC chose to con-
tinue receiving care from the clinic. Among the participants 
randomized to the community models of ART delivery arms 
[HBD and AC], overall, 95.6% chose the community mod-
els of ART delivery that they were randomized to receive 
[96.8% in the HBD arm and 94.4% in the AC arm] (Fig. 1).
Preferences for Models of ART Delivery
Out of the 2489 participants who were asked for their stated 
preference of ART delivery model, 1682 (67.6%) did not 
state a preference of model of delivery over any of the oth-
ers, 568 (22.8%) stated they would prefer home-based deliv-
ery, 125 (5.0%) stated they would prefer adherence clubs 
and 114 (4.6%) stated a preference for facility-based (SoC) 
(Table 1). Participants in the facility-based (SoC) arm were 
most likely to state a preference of one mode of ART deliv-
ery over another and of those that did state a preference the 
majority preferred HBD. Overall in the SoC arm, 39% stated 
no preference, 48% HBD, 12% AC and only 1% preferring 
SoC. Few individuals in the HBD arm stated a preference of 
one model of ART delivery over another, with 88% report-
ing no preference, and among those who did state a prefer-
ence they preferred SoC over the two community models of 
ART delivery options. In the AC arm, 73% did not state a 
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preference but amongst those that did there was a clear pref-
erence for HBD, with 19% stating this preference (Table 1). 
We found no evidence of association between stated prefer-
ence for ART delivery model and any of age, sex or time on 
ART, but did find strong evidence (p < 0.001, χ2(6) = 670.4) 
of an association with trial arm (Table 1). Among the 27 
participants in the HBD study arm who chose to receive 
SoC, all 27 stated a preference for SoC when asked. How-
ever, in the same arm, an additional 19 participants chose 
HBD despite their stated preference being for facility-based 
(SoC). Similarly in the AC arm out of the 48 participants 
who chose SoC, 46 participants stated a preference for SoC, 
one a preference for HBD and one had no preference, an 
additional 11 participants who stated a preference for SoC 
chose to join AC anyway (Table 2).
Qualitative findings from in depth interviews with 27 
study participants, revealed a number of factors that may 
have influenced participants’ preferences for HBD compared 
with AC and SoC. Congestion at the clinic was reported to 
be a prominent factor that may have influenced the pref-
erence for out of facility models, especially HBD. For all 
PLHIV interviewed, overcrowding of the ART clinic was 
the major reason why they preferred HBD. As one male 
participant reflected: ‘The issue of having too many peo-
ple at the clinic was a real problem that made the waiting 
worse.’ ‘Congestion is a real and big problem at the clinic’, 
added another female participant. CHWs also mentioned 
overcrowding at the clinic was the main reason that made 
people prefer HBD. In addition, there were a number of 
other challenges at the clinic that may have influenced the 
choice of HBD followed by AC. The waiting area at the 
Fig. 1  Uptake and choices 
across the three study arms. 
Data are n (%)
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health facility was said to be very small, with only a few 
benches that could not accommodate all clients meaning 
most had to stand in the sun for a very long time while they 
waited to be attended to. Moreover, the location of these 
waiting areas was a problem for some patients because they 
feared being seen by others while they were waiting at the 
separate ART clinic building.
“ … They say it is not fair that they are separated from 
the rest of the clinic… I have two clients, for them they 
even said they have even stopped coming to the clinic. 
‘When going to get my drugs, the location of clinic 
makes everyone to see you immediately you enter, 
and they will know that you have gone to get ARVs”. 
(FGD, CHWs, community 1).
The culture of clinic staff was also cited as reason as to 
why people preferred the HBD and the AC models. PLHIV 
complained of harsh treatment by health care workers. 
Being shouted at and the use of stigmatizing language was 
a commonly reported experience by PLHIVHs as reported 
by CHWs:
“Others felt as if they were not treated with dignity 
and respect, which caused them to get frustrated. If 
someone calls you name and you do not respond, you 
will be shouted at, ‘eh, ‘we are calling you and you 
are not answering, did you not hear your name being 
called’. So, those clients started feeling frustrated. So, 
when we came in [referring to CHiPs and the Model], 
they started saying that this was easy” (CHWs, FGD, 
community 1).
Long waiting time was another contributing factor as 
PLHIV reported coming to the clinic as early as 05.30am to 
have access to treatment early and then go for work on time.
“It was hard because there used to be huge groups of 
people at the clinic, when you go at 6 AM, you come 
Table 1  Participants stated preferences for model of ART delivery and associations between preferences and participant baseline characteristics
Data are n (%)
*Pearson’s Chi square test
Overall (n = 2489) No preference Preferred SoC Preferred HBD Preferred AC P-value*
1. Trial arm N = 1682 (67.6%) N = 114 (4.6%) N = 568 (22.8%) N = 125 (5.0%) P < 0.001
χ2(6) = 670.4 Standard of care 781 303 (38.8%) 9 (1.2%) 377 (48.3%) 92 (11.8%)
 Home based delivery 852 751 (88.1%) 46 (5.4%) 25 (2.9%) 30 (3.5%)
 Adherence clubs 856 628 (73.4%) 59 (6.9%) 166 (19.4%) 3 (0.4%)
2. Sex
 Male 732 (29.4%) 489 (66.8%) 43 (5.9%) 157 (21.4%) 43 (5.9%) 0.101
χ2(3) = 6.2 Female 1757 (70.6%) 1193 (67.9%) 71 (4.0%) 411 (23.4%) 82 (4.7%)
3. Age group
 18–24 111 82 (73.9%) 4 (3.6%) 20 (18.0%) 5 (4.5%) 0.713
χ2(12) = 8.9 25–34 610 422 (69.2%) 25 (4.1%) 135 (22.1%) 28 (4.6%)
 35–44 992 668 (67.3%) 53 (5.3%) 224 (22.6%) 47 (4.7%)
 45–54 554 360 (65.0%) 26 (4.7%) 134 (24.2%) 34 (6.1%)
 55+ 222 150 (67.6%) 6 (2.7%) 55 (24.8%) 11 (4.9%)
4. Years on ART 
  < 1 year 77 47 (61.0%) 8 (10.4%) 16 (20.8%) 6 (7.8%) 0.189
χ2(9) = 12.5 1–2 years 671 462 (68.8%) 32 (4.8%) 144 (21.5%) 33 (4.9%)
 3–5 years 829 563 (67.9%) 40 (4.8%) 192 (23.2%) 34 (4.1%)
  > 5 years 912 610 (66.9%) 34 (3.7%) 216 (23.7%) 52 (5.7%)
Table 2  Preferences amongst 
those who chose the community 
models of ART delivery versus 
those who did not
Home-based delivery arm Adherence club arm
Stated preferences Chose SoC Chose HBD Chose SoC Chose AC
No preference 0 751 1 627
Preferred standard of care 27 19 46 13
Preferred home-based delivery 0 25 1 165
Preferred adherence clubs 0 30 0 3
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back around 14–15PM.” (IDI, woman, club member, 
community 1).
For patients to avoid long queues and receive drugs 
more quickly, an informal trade between patients and 
clinic staff, especially lay counsellors, was established. 
Participants mentioned that for them to skip the queue and 
be attended to faster, they could pay staff from 10 kwachas 
($1) to 50 kwachas ($10), with the amount to be paid being 
dependent on the economic status of the client. Once this 
was done, the staff would then find means for a patient to 
be attended to in the quickest manner possible. This infor-
mal trade was perceived as adding to the waiting times for 
those patients that did not have money to pay the staff. 
Those that paid could come late and be seen before those 
that came early. This informal and hidden arrangement 
was considered to have become part of the organizational 
routines of the clinic.
“If you wanted to be attended to quickly, just pay a 
K50. In addition, it has actually become a routine, 
because for those that pay, they will spend at least an 
hour and then leave. But for those who don’t, they are 
likely to spend the whole day there” (CHWs FGD, 
community 2).
The HBD model and, to a large extent, the AC had sev-
eral advantages over the clinic. Participants described their 
experiences with the HBD and AC model as the opposite of 
that of the clinic. They reported the overriding advantage of 
HBD and AC being the convenience and control that par-
ticipants were able to retain over their time with respect to 
their livelihood activities as most of them worked in the 
informal sector which required them to leave home early in 
the morning and come back late in the evenings. The com-
munity ART models made it possible for them not to have to 
choose between going to the clinic and going to work. Drugs 
were delivered at prearranged times through an appointment 
system, enabling PLHIV to plan their work or business 
activities around this. The practice of CHWs making and 
re-confirming appointments with clients allowed them the 
mobility they required to continue livelihood activities. HBD 
was considered better than AC because drugs were delivered 
in the homes and participants did not have to move from 
their homes to a communal venue unlike the clubs.
Another factor cited by participants was the fact that 
the models were new HIV initiatives delivered by trusted 
counsellors that people already knew. The CHWs were 
well known within the communities and had built relation-
ships of trust with household members during the course 
of the main trial. When the HBD model was implemented, 
participants were free to choose it because they knew the 
people that were supposed to be delivering the interven-
tion as one CHWs reflected:
“They are welcoming, because we’ve been with them 
and we have created that rapport from the beginning. So, 
they know us” (CHWs FGD, community 2).
In all the observed home visits by CHWs, clients seemed 
very happy with the visit, greeting the CHWs with smiles. 
During the interviews, participants were asked about their 
view on the models and asked to plot their overall opinion 
of the HBD and AC on a simple visual scale with different 
facial expressions (emoji’s) corresponding to the degrees of 
satisfaction from not at all satisfied to extremely satisfied. The 
majority of PLHIV gave the model a score of 5/5, indicating 
they were extremely satisfied with the way the model had fit 
into their lives. This satisfaction is reflected in the following 
quote from one of the participants.
“Well, I am very happy with this programme and eve-
rything that happens in it. It has reduced the problems I 
used to face when I used to go to the clinic, making us 
stand in queues, leaving the clinic late; it has reduced all 
of that.” (IDI, Woman, Community 2).
When comparing the number of study participants that 
said they were either very satisfied or extremely satisfied with 
the two models, the HBD had more PLHIV expressing high 
levels of satisfaction than those that were from AC. A few 
participants rated the model four out of five indicating they 
still faced problems with follow-up procedures at the facility 
whilst others were neutral about the clubs because they felt the 
clubs should rather meet every 6 months than 3 months to give 
them enough time for their livelihood activities.
Both HBD and AC were seen as models that reduced 
the stigma previously experienced at the clinic. Accessing 
ART from dedicated areas in the local clinic was interwo-
ven with fears about ‘being seen accessing ART’ and being 
recognised as a person with HIV. Establishing the HBD on 
the back of a door-to-door HIV testing programme and using 
the same people (CHWs) was mentioned by the majority 
of PLWH as one major factor that minimized stigma dur-
ing the home visits. The existence of the prior programme 
helped veil the delivery of ARVs as everyone identified the 
CHWs with the HIV testing programme and not with the 
ART delivery programme.
‘My neighbours do not know the reason why they visit 
me but what they do know is that they move door to 
door in each and every household checking on people.” 
(IDI, woman, community 2).
Discussion
This manuscript describes the choices and stated prefer-
ences of models of ART delivery amongst a group of stable 
people living with HIV who consented to enrol into a CRT 
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comparing acceptability and safety of two different models 
of delivering ART outside of current facility based care with 
the standard of care. In our study population, over 95% chose 
the community models of ART delivery rather than facility-
based (SoC) when offered a choice (as their “revealed prefer-
ence”). When asked to express their preference for a mode 
of ART delivery, over 65% did not state a preference but for 
those who stated a preference, there was an overwhelming 
acceptance and enthusiasm for community models of ART 
delivery options.
Our findings confirm that decentralizing ART care 
outside the current facility-based care into the communi-
ties using community health workers to provide adherence 
support and pre-packed medications is feasible and accept-
able. This is consistent with findings from previous studies 
which have shown that community-based ART programs 
can achieve remarkable results in expanding access to treat-
ment and retention in resource limited settings [29] as they 
overcome many of the challenges patients face such as long 
waiting times to access medications, frequent clinic trips 
and transportation costs [30–33]. An analysis of program-
matic data by Broad Reach International [34] from 217 
facilities in five districts in South Africa between 2016 
and 2017, showed rapid uptake of differentiated models of 
care (facility and out-of-facility based) with approximately 
75% of eligible patients accepting and a 10% increase in 
patients moving to community based models. However, it 
is unknown whether patients in this analysis were offered a 
choice between the models and standard of care. Similarly, 
the HPTN 071 (PopART) trial showed that using Commu-
nity HIV providers (CHiPs) to provide a door-to-door com-
bination HIV package is well accepted, feasible and effective 
in coverage of HIV testing and knowledge of status in both 
adults and adolescents [35, 36]. To-date there is limited data 
documenting patient choices and preferences towards mod-
els of ART delivery in resource-limited settings as well as 
factors associated with the choices patients make towards 
non-facility based care although location-related preferences 
appeared prominent [37], with most patients citing long 
waiting times, overcrowding and distance as the real reason 
for their choice. Findings from a recent study in Zambia 
using discrete choice experiments to ass stable HIV patient’s 
preferences towards differentiated care models demonstrated 
substantial heterogeneity with the strongest overall prefer-
ence for reduced clinic visits [25].
Exploring choices and preferences that patients make 
towards health care in resource limited settings is difficult 
and there is very limited data on health decision making by 
patients in these settings. A review of literature has revealed 
that patient involvement in health care decision making is 
empowering and has been associated with improved treat-
ment outcomes [38]. Recognition of a patient’s knowl-
edge, health care worker- patient relationship, allocation 
of sufficient time for participation and also factors associ-
ated with patient’s knowledge, beliefs, physical and cogni-
tive abilities and values can influence patient participation 
in health care decisions [38]. In resource limited settings, 
health care workers with constrained resources are unable 
to offer a choice and instead dictate to the patient who are 
therefore unused to being asked to express their own choices 
and usually do not, for fear of being neglected in care. 
Patients may struggle to choose between health care options 
as they lack confidence, may not be sure of the options they 
would prefer or have conflicting priorities [39]. In resource-
constrained settings, patient’s choices tend to be influenced 
by structural aspects of the health care service such as avail-
ability and accessibility of health care providers, quality of 
staff, costs of treatment and by processes such as availability 
of information, continuity of treatment, waiting time and 
transport costs [40]. This could explain the reason why 
patients would “choose” the interventions offered to them.
In our study population, over 95% of the participants in 
the community models of ART delivery arms who were 
offered a choice between community and facility-based care 
options chose the former. It may be understandable that bar-
riers such as location, distance to clinic, overcrowding and 
long waiting times are important factors and whilst these 
barriers are well known determinants of uptake, accept-
ability and outcomes [41], reasons for choosing commu-
nity models of ART delivery may vary. When determin-
ing patient preferences, 1/3 of our study population stated a 
preference towards a model of ART delivery and of these, 
majority stated a preference for community models of ART 
delivery (HBD and AC) compared to SoC. A large propor-
tion, 2/3 of the study population did not state a preference 
towards any of the 3 ART delivery options and whether that 
reflects a true lack of preference needs to be explored fur-
ther. Some of the possible explanations as to why our study 
participants were unwilling to state a preference could be 
that: (1) They do not perceive themselves as having much 
autonomy of choice when it comes to health care services; 
(2) They are not empowered about choice especially in 
resource-limited and (3) The design of our study where par-
ticipants were assigned to the study arm before they were 
asked on their preferences and therefore less likely to state 
a preference when satisfied with what they had received, for 
example, only 11.9% of participants in the HBD arm actually 
stated a preference compared with 61.2% in the Soc arm. 
In the study arms where participants did not get an option 
off being in HBD, a higher stated preference towards HBD 
was observed over the other two options. In both HBD and 
AC arms, participants were less likely to state preferences 
towards the modes of ART delivery.
Although several studies have suggested increasing expe-
rience of stigma by household members who were receiving 
follow-up visits by community health workers to link to care 
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when tested positive [42], it appears that in our study, the 
high acceptability of community models of care by partici-
pants did not perceive community health workers providing 
HIV support and drug delivery in their homes or community 
venues as stigmatizing. This could largely be due to the fact 
that during the HPTN 071 (PopART) trial, repeated home 
visits by community health workers delivering the door-to-
door combination prevention package over the course of 
3 years solidified the relationship between CHWs and the 
communities and could also have changed the communi-
ties perception towards these cadres [35, 43]. However, we 
cannot say how these findings may be generalizable to other 
settings that do not have community workers delivering HIV 
interventions.
The study had a number of limitations. First this study 
was done in an urban setting where patients have never been 
exposed to community models of ART delivery or other 
forms of differentiated care offered by the government as 
part of their health care services, and therefore may not 
have been able to or could have struggled to determine their 
preferences towards community models of ART delivery 
unknown to them. Secondly, the design of our study where 
participants were asked for their preference only after they 
were assigned to the study arms could have led to bias. It 
is possible that had we asked for their preferences prior to 
them knowing which mode of ART delivery they were being 
allocated to, we may have found a different outcome.
Our review sheds light for future opportunities to conduct 
preference studies in resource-limited settings. As HIV pro-
grams scale up community models of ART delivery in the 
context of universal treatment, there is need to further iden-
tify patient and provider preferences for community models 
of care that will improve clinical outcomes.
Conclusion
Offering PLHIV a choice of different models of ART care in 
high-burden resource limited settings is possible and when 
offered a choice between facility and community models of 
ART delivery, the majority of those who expressed a pref-
erence stated a preference for home-based ART delivery, 
the revealed preference when the option was implemented 
was over 95%. As national programs scale up models of 
ART delivery in resource- limited settings, acceptability, 
choices and preferences will be important in order to deter-
mine which models to prioritize as they could be significant 
factors in clinical outcomes and integrity of the models of 
delivery.
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